Greenwich Share Price

Greenwich Share Price

NASDAQ: GLSI | Micro Cap | Healthcare
$20.53
+$1.96 (10.55%) Last updated on 19 Nov, 2026 | 01:25 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

Greenwich Stock Performance

Open
$19.50
Prev. Close
$18.57
Circuit Range
N/A
Day Range
$18.95 - $21.49
Year Range
$7.83 - $33.91
Volume
14,833
Average Traded
$20.45

Greenwich Share Price Today

As of 19 November 2026, Greenwich LifeSciences, Inc.'s share price is $20.53. The stock opened at $19.50, compared to its previous close of $18.57. During today's trading session, Greenwich LifeSciences, Inc.'s share price traded between $18.95 and $21.49, with an average price of $20.22. Over the past 52 weeks, the stock has recorded a high of $33.91 and a low of $7.83. In terms of performance, Greenwich LifeSciences, Inc.'s share price has declined by 22.35% over the last six months and is up 135.98% on a year-on-year basis.

Greenwich Share Price Chart

Line chart of the Greenwich price trend over the selected period. The price rose overall, ranging from 18.61 to 21.65, ending at 20.53.
$18.95$21.49
L
Show Current Price
H

Greenwich Stock Fundamentals & Key Indicators

Market Cap
$267.19M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-1.48
Revenue (TTM)
$0.00
Return On Equity (TTM)
-695.56%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
4.82%

Greenwich Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$4.15-$7.92-$5.66-$3.95
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-90.84%28.54%30.21%

Greenwich Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$0.00$0.00
Net Profit-$7.83-$8.89-$17.41-$19.36
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-13.54%-95.84%-11.20%

Greenwich Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets0.00.00.010.01
Current Assets6.184.096.9913.47
Total Assets6.184.096.9913.48
Non Current Liabilities0.00.00.00.0
Current Liabilities5.823.190.290.26
Total Liabilities5.823.190.290.26
Shareholders' Equity0.350.916.713.21

Greenwich Cash Flow

Annually
Particulars2025202420232022
Operating (USD Million)-9.91-7.27-6.48-6.2
Investing (USD Billion)0.00.00.00.0
Financing (USD Million)12.04.370.0-7.54

About Greenwich

Greenwich LifeSciences Inc a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, Flamingo-01, which is evaluating GLSI-100, an immunotherapy to prevent breast cancer recurrences. GP2 is a 9-amino-acid transmembrane peptide of the HER2/neu protein, a cell surface receptor protein that is expressed in a variety of common cancers, including breast cancers at low (1+), intermediate (2+), and high (3+ or overexpressing) levels.

Greenwich Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$16.56
$20.51
+18.08%
Oct 2026
$18.13
$17.37
-5.19%
Sep 2026
$14.59
$18.32
-0.65%
Aug 2026
$13.75
$18.44
+39.27%
Jul 2026
$24.27
$13.24
-43.95%
Jun 2026
$28.11
$23.62
-10.67%
May 2026
$24.32
$26.44
+13.38%
Apr 2026
$24.38
$23.32
-2.91%
Mar 2026
$27.99
$24.02
-14.12%
Feb 2026
$30.65
$27.97
-5.44%
Jan 2026
$20.55
$29.58
+39.27%
Dec 2025
$8.60
$21.24
+144.14%

Greenwich Share Price FAQs